Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Clin Lab ; 49(7-8): 357-65, 2003.
Artículo en Inglés | MEDLINE | ID: mdl-12908735

RESUMEN

We investigated the usefulness of a colorimetric method based on the reduction of a tetrazolium salt (XTT) for the susceptibility testing of clinical isolates of Mycobacterium tuberculosis to isoniazid, rifampin, rifabutin, ethambutol hydrochloride, ethionamide and streptomycin. The isolates and the ATCC reference strains reported as susceptible according to the agar dilution method approved by the National Committee for Clinical Laboratory Standards were found to be susceptible by the XTT colorimetric assay after times of incubation ranging between three days for rifampin and rifabutin to eight days for isoniazid. In comparison with other colorimetric methods reviewed in this article, the proposed assay is suitable for determining the susceptibility or resistance to most antituberculous drugs and, as a consequence of the water-solubility of the formazan yielded by reduction of XTT, additional steps such as the addition of extraction buffer and further incubation before the spectrophotometric analysis are not needed. The XTT reduction assay is an inexpensive, rapid and reliable screening method for the detection of susceptible, resistant and multidrug-resistant strains of M. tuberculosis and is an alternative to the costly performance of molecular or radiometric methods.


Asunto(s)
Antituberculosos/farmacología , Indicadores y Reactivos , Pruebas de Sensibilidad Microbiana/métodos , Mycobacterium tuberculosis/efectos de los fármacos , Sales de Tetrazolio , Colorimetría/métodos , Farmacorresistencia Bacteriana , Humanos , Técnicas In Vitro , Pruebas de Sensibilidad Microbiana/normas , Mycobacterium tuberculosis/crecimiento & desarrollo , Mycobacterium tuberculosis/aislamiento & purificación , Tuberculosis Resistente a Múltiples Medicamentos/tratamiento farmacológico , Tuberculosis Resistente a Múltiples Medicamentos/microbiología
2.
Int J Antimicrob Agents ; 21(3): 244-50, 2003 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-12636986

RESUMEN

The susceptibility or resistance of clinical isolates of Mycobacterium tuberculosis were determined by a method incorporating the 2,3-bis(2-methoxy-4-nitro-5-sulphophenyl)-2H-tetrazolium-5-carboxanilide (XTT) and compared with results obtained by the National Committee for Clinical Laboratory Standards approved standard method (M24-T2). One hundred percent of all isolates demonstrated agreement between the susceptibility and resistance to isoniazid, rifampicin, and ethambutol obtained by the two methods, suggesting that the XTT-based method could provide a useful means for the rapid determination of antimycobacterial susceptibility of clinical isolates of M. tuberculosis.


Asunto(s)
Pruebas de Sensibilidad Microbiana/métodos , Mycobacterium tuberculosis/efectos de los fármacos , Antituberculosos/farmacología , Recuento de Colonia Microbiana , Colorimetría/métodos , Farmacorresistencia Bacteriana , Humanos , Técnicas In Vitro , Pruebas de Sensibilidad Microbiana/normas , Mycobacterium tuberculosis/crecimiento & desarrollo , Mycobacterium tuberculosis/aislamiento & purificación , Sales de Tetrazolio , Tuberculosis Resistente a Múltiples Medicamentos/tratamiento farmacológico , Tuberculosis Resistente a Múltiples Medicamentos/microbiología
3.
Bioorg Med Chem ; 10(3): 501-6, 2002 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-11814835

RESUMEN

A new series of S-alkylisothiosemicarbazones of 3- and 4-pyridincarboxaldehyde and 4-fluoro- and 4-trifluoromethylbenzaldehyde was synthesized and evaluated for biological activity against various Mycobacterium strains. Inhibitory activity against Mycobacterium tuberculosis H37Rv ATCC 27294 and INH-R ATCC 35822 was compared with activity against clinical isolated Mycobacteria as well as against MOTT. Some of newly prepared compounds showed best inhibitory values against clinical isolated Mycobacteria, besides to low citotoxicity values.


Asunto(s)
Antibacterianos/síntesis química , Tiosemicarbazonas/síntesis química , Animales , Antibacterianos/farmacología , División Celular/efectos de los fármacos , Chlorocebus aethiops , Pruebas de Sensibilidad Microbiana , Mycobacteriaceae/efectos de los fármacos , Mycobacterium tuberculosis/efectos de los fármacos , Relación Estructura-Actividad , Tiosemicarbazonas/farmacología , Células Vero
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA